Epigenetics

产品 151 到 200 共 474个

每页
页面:
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6

设置升序顺序
  1. XL019

    Catalog No. A12394
    Quick View
    JAK2 抑制剂
    XL019是janus相关激酶2 (JAK-2)的生物可利用抑制剂,具有潜在的抗肿瘤活性。 了解更多
  2. PF-03394197 (oclacitinib)

    Catalog No. A13082
    Quick View
    JAK1 抑制剂
    PF-03394197 (oclacitinib)是有效的JAK1抑制剂。 了解更多
  3. GLPG0634

    Catalog No. A13162
    Quick View
    JAK1 抑制剂
    GLPG0634是一种口服的JAK1(Janus激酶1)选择性抑制剂,对 JAK1/JAK2/JAK3的IC50值为50-200 nM。用于治疗类风湿性关节炎和潜在的其他炎性疾病。 了解更多
  4. Pyridone 6 (JAK Inhibitor I)

    Catalog No. A13457
    Quick View
    JAK 抑制剂
    JAK Inhibitor I 是JAK1、JAK2和JAK3的一种高效、可逆、细胞通透性和ATP竞争性抑制剂。 了解更多
  5. WHI-P 154

    Catalog No. A14049
    Quick View
    JAK3 抑制剂
    WHI-P 154是一种JAK3抑制剂,IC50 = 1.8uM。WHI-P 154还在体外抑制巨噬细胞中的STAT1激活,iNOS表达和NO生成。 了解更多
  6. PRT 062070 (Cerdulatinib)

    Catalog No. A14147
    Quick View
    Dual Syk and JAK 抑制剂
    PRT 062070 (Cerdulatinib)是一种新型的口服双脾酪氨酸激酶(Syk)和janus激酶(JAK)抑制剂。Cerdulatinib优先抑制各种细胞类型中JAK1和JAK3依赖性细胞因子介导的信号传导和功能性反应。 了解更多
  7. NSC 42834(JAK2 Inhibitor V, Z3)

    Catalog No. A14132
    Quick View
    JAK2 抑制剂
    NSC 42834(JAK2 Inhibitor V,Z3)是一种新型的Jak2酪氨酸激酶特异性抑制剂。 了解更多
  8. Cerdulatinib

    Catalog No. A14210
    Quick View
    multi-targeted tyrosine kinase 抑制剂
    Cerdulatinib (PRT-062070)是多靶点酪氨酸激酶抑制剂,对JAK1/JAK2/JAK3/TYK2和Syk的IC50分别为12 nM/6 nM/8 nM/0.5 nM和32 nM。 了解更多
  9. Filgotinib

    Catalog No. A14232
    Quick View
    JAK 抑制剂
    Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。 了解更多
  10. INCB39110 (Itacitinib)

    Catalog No. A14390
    Quick View
    JAK1 抑制剂
    INCB39110 (Itacitinib)是一种有效的JAK1酪氨酸激酶抑制剂,目前正在II期试验中,用于治疗类风湿关节炎,骨髓纤维化,类风湿关节炎和斑块状牛皮癣。 了解更多
  11. Solcitinib (GSK2586184)

    Catalog No. A14405
    Quick View
    JAK1 抑制剂
    Solcitinib (GSK2586184)是Janus激酶1(JAK1)抑制剂。 了解更多
  12. Decernotinib

    Catalog No. A14012
    Quick View
    JAK3 抑制剂
    Decernotinib是Vertex开发的口服选择性Janus激酶3(JAK3)抑制剂。 了解更多
  13. ZM 39923 HCl

    Catalog No. A13509
    Quick View
    JAK3 抑制剂
    ZM 39923 HCl是JAK3抑制剂(IC50 = 79 nM),其抑制表皮生长因子受体,JAK1和细胞周期蛋白依赖性激酶4(IC50s分别为2.4、40和10 M)的抑制作用较小。 了解更多
  14. S-Ruxolitinib

    Catalog No. A14955
    Quick View
    JAK 抑制剂
    S-Ruxolitinib是INCB018424的手性化合物,是一种有效且选择性的小分子Janus激酶1(JAK1)和JAK2抑制剂。 了解更多
  15. CYT387 sulfate salt

    Catalog No. A15056
    Quick View
    JAK 抑制剂
    CYT387 sulfate salt是JAK1/JAK2的ATP竞争性抑制剂,IC50为11 nM/18 nM,是JAK3的约10倍选择性。 了解更多
  16. JANEX-1

    Catalog No. A15134
    Quick View
    JAK3 抑制剂
    Janex-1是JAK3的细胞渗透性,可逆性,有效,ATP竞争性和特异性抑制剂(IC50 = 78 uM);对JAK1,JAK2或Zap/Syk或SRC酪氨酸激酶无影响。 了解更多
  17. 1,2,3,4,5,6-Hexabromocyclohexane

    Catalog No. A15361
    Quick View
    JAK2 抑制剂
    1,2,3,4,5,6-Hexabromocyclohexane是一种有效且特异性的JAK2自磷酸化抑制剂。 了解更多
  18. Cercosporamide

    Catalog No. A15362
    Mnk2/JAK3 抑制剂
    Cercosporamide是一种USnic酰胺,最初在Cercosporidium henningsii中被鉴定为宿主选择性植物毒素和广谱抗真菌剂,并且是MAP激酶相互作用激酶2(Mnk2;IC50 = 11 nM),JAK3(IC50 = 31)和Mnk1(IC50 = 116 nM)。 了解更多
  19. Cucurbitacin I

    Catalog No. A15363
    JAK2/STAT3 抑制剂
    Cucurbitacin I(Cucumis sativus L.)可以抑制v-Src转化的NIH 3T3细胞中的磷酸酪氨酸Stat3(信号转导和转录激活因子3)水平。 了解更多
  20. SD 1008

    Catalog No. A15364
    Quick View
    JAK2/STAT3 抑制剂
    SD 1008是JAK2/STAT3信号通路抑制剂,可额外抑制Src。注意到SD 1008可诱导表达组成性活性酪氨酸磷酸化STAT3的细胞系凋亡。 了解更多
  21. TCS 21311

    Catalog No. A15365
    Quick View
    JAK3 抑制剂
    TCS 21311是有效的JAK3抑制剂(IC50 = 8 nM)。TCS 21311对于JAK3相对于JAK1,JAK2和Tyk 2具有选择性(IC50值分别为1017、2550和8055 nM)。 了解更多
  22. ZM 449829

    Catalog No. A15366
    Quick View
    JAK/STAT 抑制剂
    ZM 449829是有效的、选择性的JAK3抑制剂(Janus酪氨酸激酶3),与JAK3 ATP位点竞争性结合。 了解更多
  23. NSC 33994

    Catalog No. A15389
    Quick View
    JAK2 抑制剂
    NSC 33994是JAK2酪氨酸激酶(Janus激酶2)的新型抑制剂。Janus激酶2(JAK2)在骨髓增生性疾病和血液系统恶性肿瘤的发病机制中起着至关重要的作用。 了解更多
  24. Baricitinib phosphate

    Catalog No. A15014
    Quick View
    JAK 抑制剂
    Baricitinib phosphate是一种选择性的JAK1和JAK2抑制剂,IC50为5.9 nM和5.7 nM,选择性是JAK3和Tyk2的?70和?10倍,对c-Met和Chk2没有抑制作用。 了解更多
  25. Peficitinib (ASP015K, JNJ-54781532)

    Catalog No. A14438
    Quick View
    JAK 抑制剂?
    Peficitinib (ASP015K,JNJ-54781532)是一种新型的强力JAK抑制剂,在佐剂诱导的大鼠关节炎模型中显示出强效功效。 了解更多
  26. FLLL32

    Catalog No. A15911
    Quick View
    JAK2 抑制剂
    FLLL32是一种有效的JAK2/STAT3双重抑制剂,IC50 <5 uM。 了解更多
  27. WHI-P97

    Catalog No. A11608
    Quick View
    JAK3 抑制剂
    WHI-P97是合理设计的JAK-3抑制剂。 了解更多
  28. NS-018

    Catalog No. A16224
    Quick View
    JAK2 抑制剂
    NS-018是Janus相关激酶2(JAK2)和Src家族激酶的口服生物利用型小分子抑制剂,具有潜在的抗肿瘤活性。 了解更多
  29. NS-018 hydrochloride

    Catalog No. A16225
    Quick View
    JAK2 抑制剂
    NS-018 hydrochloride是一种新型的高选择性JAK2抑制剂。 了解更多
  30. NS-018 maleate

    Catalog No. A16226
    Quick View
    JAK2 抑制剂
    NS-018 maleate是在Ba/F3-JAK2V617F细胞中具有ATP竞争性的JAK2小分子抑制剂,IC50为470nM。与其他JAK家族激酶(例如JAK1,JAK3和酪氨酸激酶2)相比,对JAK2的选择性高30-50倍。 了解更多
  31. ZM39923

    Catalog No. A16227
    Quick View
    JAK1/3 抑制剂
    ZM39923是一种JAK1/3抑制剂,pIC50为4.4/7.1,对JAK2几乎没有活性,对EGFR的作用中等。还发现对转谷氨酰胺酶敏感。 了解更多
  32. Gusacitinib

    Catalog No. A19883
    Quick View
    SYK/JAK inhibitor
    Gusacitinib (ASN-002) is a potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 values of 5-46 nM. 了解更多
  33. TG-02 (SB1317)

    Catalog No. A11962
    Quick View
    FLT3 抑制剂
    TG-02 (SB1317)是一种新型的小分子有效CDK/JAK2/FLT3抑制剂。 了解更多
  34. CHZ868

    Catalog No. A15937
    Quick View
    JAK2 抑制剂
    CHZ868是一种有效的选择性II型JAK抑制剂,在JAK抑制剂持续性细胞,鼠类MPN模型和MPN患者样品中显示出活性。 了解更多
  35. SB1317 (TG02)

    Catalog No. A13454
    Quick View
    CDK/JAK2/FLT3 抑制剂
    SB1317是细胞周期蛋白依赖性激酶(CDKs)、类FMS酪氨酸激酶-3(FLT3)和Janus激酶2(JAK2)的有效抑制剂,CDK2、JAK2和FLT3的IC50值分别为13nM、56nM和73nM。 了解更多
  36. FM-381

    Catalog No. A16805
    Quick View
    JAK3 抑制剂
    FM-381是一种JAK3特异性可逆共价抑制剂,对JAK3的IC50为127 pM,相对于JAK1,JAK2和TYK2分别具有400、2、700和3,600倍的选择性。 了解更多
  37. PF-06651600

    Catalog No. A16803
    Quick View
    JAK3 抑制剂
    PF-06651600是一种有效且不可逆的JAK3选择性抑制剂,IC50为33.1 nM,但对JAK1,JAK2和TYK2没有活性(IC50> 10 000 nM)。 了解更多
  38. Ruxolitinib Phosphate

    Catalog No. A11552
    Quick View
    JAK 抑制剂
    Ruxolitinib Phosphate是ruxolitinib的磷酸盐形式,ruxolitinib是一种口服生物可利用的Janus相关激酶(JAK)抑制剂,具有潜在的抗肿瘤和免疫调节活性。 了解更多
  39. PF-06700841 tosylate

    Catalog No. A17176
    Quick View
    JAK1 and TYK2 抑制剂
    PF-06700841 tosylate是JAK1和TYK2激酶的抑制剂。 了解更多
  40. JAK3-IN-2

    Catalog No. A18323
    Quick View
    JAK3 抑制剂
    JAK3-IN-2 is a potent and highly selective JAK3 inhibitor with IC50 of 0.15 nM. dispalys >4,300-fold selectivity over JAK1, JAK2 and TYK2, and other kinases BMX, EGFR, ITK and BTK; blocks cytokine signaling through JAK3, but not through other JAK family enzymes; inhibits IL-7 induced pSTAT5 in CD3+, CD8+ T cells with IC50 of 280 nM; sufficiently blocks the development of inflammation in a rat model of rheumatoid arthritis, while sparing hematopoiesis. 了解更多
  41. Abrocitinib (PF-04965842)

    Catalog No. A18318
    Quick View
    JAK1 抑制剂
    Abrocitinib (PF-04965842) is a potent, orally active and selective JAK1 inhibitor, with IC50s of 29 and 803 nM for JAK1 and JAK2, respectively. Abrocitinib (PF-04965842) exhibits less active effect on TYK2 (IC50, 1.253 μM), and inhibits phosphorylation of STAT1, STAT3 and STAT5 after stimulation. Effective in autoimmune disease. 了解更多
  42. WHI-P258

    Catalog No. A18317
    Quick View
    JAK3 抑制剂
    WHI-P258 is a quinazoline compound that modeling studies suggested would bind to the active site of JAK3 with an estimated Ki value of 72 uM. 了解更多
  43. Upadacitinib (ABT-494)

    Catalog No. A18316
    Quick View
    JAK-1 抑制剂
    Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders with an IC50 of 43 nM. IC50 & Target: IC50: 43 nM (JAK1), 200 nM (JAK2) 了解更多
  44. BMS-986165

    Catalog No. A18726
    Quick View
    TYK2 抑制剂
    BMS-986165 is a Highly Potent and Selective Allosteric Inhibitor of TYK2. BMS-986165 Blocks Il-12, IL-23 and type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Inflammatory Bowel Disease. 了解更多
  45. Tyk2-IN-8

    Catalog No. A19052
    Quick View
    TYK2 抑制剂
    Tyk2-IN-8 (compound 10) is a selective TYK2 inhibitor, which binds to TYK2 catalytically active JH1 domain with an IC50 of 17 nM, used in the treatment of psoriasis. 了解更多
  46. JAK1-IN-7

    Catalog No. A19029
    Quick View
    JAK1 抑制剂
    JAK1-IN-7 is a Janus-associated kinase 1 (JAK1) inhibitor extracted from patent WO2018134213A1, Example 63, has an anti-inflammatory effect. 了解更多
  47. JAK3 covalent inhibitor-1

    Catalog No. A18926
    Quick View
    JAK3 covalent 抑制剂
    JAK3 covalent inhibitor-1 is a potent and selective janus kinase 3 (JAK3) covalent inhibitor with an IC50 of 11 nM and shows 246-fold selectivity vs other JAKs. 了解更多
  48. JAK1-IN-4

    Catalog No. A18821
    Quick View
    JAK1 抑制剂
    JAK1-IN-4 is a potent and selective JAK1 inhibitor, with IC50s of 85 nM, 12.8 μM and >30 μM for JAK1, JAK2, and JAK3, respectively. JAK1-IN-4 inhibits STAT3 phosphorylation in NCI-H 1975 cells (IC50, 227 nM). 了解更多
  49. Tofacitinib

    Catalog No. A17252
    Quick View
    JAK3/2/1 inhibitor
    Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively. 了解更多
  50. PF-06263276

    Catalog No. A12572
    Quick View
    pan-JAK inhibitor
    PF-06263276 (PF 6263276) is a potent and selective pan-JAK inhibitor, with IC50s of 2.2 nM, 23.1 nM, 59.9 nM and 29.7 nM for JAK1, JAK2, JAK3 and TYK2, respectively. 了解更多

产品 151 到 200 共 474个

每页
页面:
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6

设置升序顺序
Rewards